At the leading edge of innovation, HORIBA Medical’s products are internationally recognized.
Its flexible production facilities and innovative R&D are major assets that allow it to develop solutions that meet market demand and the particular needs of its customers.
Its Hematology expertise has earned Horiba Medical a reputation among the biggest specialists of in vitro diagnostics.

Key indicators

  • Over 1,100 employees
  • 4 production centers (Japan, China, France, Brazil)
  • 2 R&D centers (Japan, France)
  • Around 100 distributors
  • 13 local/direct operations
  • Around 30,000 laboratories supplied worldwide
Biological markers for screening

25 Jun 2020 - Haematology biomarkers for COVID-19 assessment discussed in new HORIBA Medical White Paper

25 Jun 2020 - How routinely measured biological markers could contribute to the monitoring of Coronavirus...

Read more

World Blood Cancer Day

28 May 2020 - HORIBA UK Limited is raising awareness of the World Blood Cancer Day

28 May 2020 - HORIBA UK Limited is raising awareness of the World Blood Cancer Day and shows support to people...

Read more

Microsemi CRP

26 May 2020 - New HORIBA Medical POC analysers helping to keep vulnerable patients safer in Cornwall

26 May 2020 - Microsemi CRP haematology analysers installed during COVID-19 ‘lockdown’ in POC locations to reduce...

Read more